Search research articles
Contact Us
Filters
Showing results (91-100 of 224) with videos related to
Page
of 23
Sort By:
Frontiers in Immunology
|
December 6, 2021
Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis
Jérôme Razanamahery, Anne Roggy, Jean-François Emile, et al.
European Journal of Internal Medicine
|
October 14, 2014
Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia
Mathieu Blot, Pierre Boyer, Maxime Samson, et al.
Clinical and Experimental Rheumatology
|
May 3, 2021
A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects
Ségolène Perrineau, Thibault Ghesquière, Pierre Charles, et al.
European Journal of Internal Medicine
|
May 11, 2021
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases
Paul Decker, Thomas Moulinet, Benjamin Lopez, et al.
Cancers
|
July 9, 2022
Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database
Yves Cottin, Mathieu Boulin, Clara Doisy, et al.
Journal of the American Medical Directors Association
|
September 8, 2016
A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients
Alain Putot, Jennifer Tetu, Sophie Perrin, et al.
Rheumatology (Oxford, England)
|
April 1, 2021
Heamatological malignancies in giant cell arteritis: a French population-based study
Hélène Greigert, Morgane Mounier, Louis Arnould, et al.
Oncoimmunology
|
December 8, 2018
Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma
Aurélie Collignon, Françoise Silvy, Stéphane Robert, et al.
American Journal of Hematology
|
June 27, 2013
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, et al.
Heart and Vessels
|
August 10, 2021
Acute myocarditis with autoimmune features: one-year follow-up with CMR
Céline Lairet, Hélène Greigert, Thibaut Pommier, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 224) with videos related to
Sort By:
Page
of 23
Frontiers in Immunology
|
December 6, 2021
Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis
Jérôme Razanamahery, Anne Roggy, Jean-François Emile, et al.
European Journal of Internal Medicine
|
October 14, 2014
Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia
Mathieu Blot, Pierre Boyer, Maxime Samson, et al.
Clinical and Experimental Rheumatology
|
May 3, 2021
A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects
Ségolène Perrineau, Thibault Ghesquière, Pierre Charles, et al.
European Journal of Internal Medicine
|
May 11, 2021
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases
Paul Decker, Thomas Moulinet, Benjamin Lopez, et al.
Cancers
|
July 9, 2022
Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database
Yves Cottin, Mathieu Boulin, Clara Doisy, et al.
Journal of the American Medical Directors Association
|
September 8, 2016
A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients
Alain Putot, Jennifer Tetu, Sophie Perrin, et al.
Rheumatology (Oxford, England)
|
April 1, 2021
Heamatological malignancies in giant cell arteritis: a French population-based study
Hélène Greigert, Morgane Mounier, Louis Arnould, et al.
Oncoimmunology
|
December 8, 2018
Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma
Aurélie Collignon, Françoise Silvy, Stéphane Robert, et al.
American Journal of Hematology
|
June 27, 2013
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, et al.
Heart and Vessels
|
August 10, 2021
Acute myocarditis with autoimmune features: one-year follow-up with CMR
Céline Lairet, Hélène Greigert, Thibaut Pommier, et al.
Page
of 23